Get the Stockscreener App
1.42
2.07%
-0.03
After Hours:
1.49
0.07
+4.93%
Hillevax Inc stock is traded at $1.42, with a volume of 665.78K.
It is down -2.07% in the last 24 hours and down -20.22% over the past month.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
See More
Previous Close:
$1.45
Open:
$1.44
24h Volume:
665.78K
Relative Volume:
3.39
Market Cap:
$71.20M
Revenue:
-
Net Income/Loss:
$-123.57M
P/E Ratio:
-0.4671
EPS:
-3.04
Net Cash Flow:
$-97.53M
1W Performance:
-10.69%
1M Performance:
-20.22%
6M Performance:
-19.77%
1Y Performance:
-90.21%
1-Day Range:
$1.34
$1.495
1-Week Range:
$1.34
$1.57
52-Week Range:
$1.34
$16.30
Hillevax Inc Stock (HLVX) Company Profile
Name
Hillevax Inc
Sector
Industry
Phone
(617) 213-5054
Address
321 HARRISON AVE, SUITE 500, BOSTON
Compare HLVX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HLVX
Hillevax Inc
|
1.42 | 71.20M | 0 | -123.57M | -97.53M | -3.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Hillevax Inc Stock (HLVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-09-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-09-24 | Downgrade | Stifel | Buy → Hold |
| Jul-08-24 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-13-23 | Initiated | H.C. Wainwright | Buy |
View All
Hillevax Inc Stock (HLVX) Latest News
HKVX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Investors to Contact the Firm Today! - ACCESS Newswire
HilleVax (NASDAQ:HLVX) Given Neutral Rating at HC Wainwright - Defense World
Cautious Hold Rating on HilleVax Amid Norovirus Vaccine Development Setbacks - TipRanks
HilleVax Reports 2024 Financial Results Amid Strategic Exploration - MSN
HilleVax Inc. (HLVX) reports earnings - Quartz
HilleVax, Inc. SEC 10-K Report - TradingView
HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress - The Manila Times
Shareholder Rights Advocates at Levi & Korsinsky Investigate HilleVax, Inc. (HLVX) Regarding Possible Securities Fraud Violations - ACCESS Newswire
HilleVax (HLVX) to Release Quarterly Earnings on Wednesday - Defense World
HILLEVAX Earnings Preview: Recent $HLVX Insider Trading, Hedge Fund Activity, and More - Nasdaq
HilleVax (NASDAQ:HLVX) & Omega Therapeutics (NASDAQ:OMGA) Critical Survey - Defense World
HKVX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Investors to Contact the Firm! - ACCESS Newswire
Hillevax CFO Shane Maltbie sells $15,116 in stock By Investing.com - Investing.com Nigeria
Stocks of HilleVax Inc (HLVX) are poised to climb above their peers - SETE News
Hillevax CEO Robert Hershberg sells $48,661 in stock - MSN
HilleVax, Inc. (NASDAQ:HLVX) Shares Purchased by SG Americas Securities LLC - Defense World
Hillevax CFO Shane Maltbie sells $15,116 in stock - MSN
HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by Qiming U.S. Ventures Management LLC - MarketBeat
Top Executives Cash In on HilleVax Stock Sales - TipRanks
HilleVax Executives Sell Shares in February 2025 - TradingView
Vitro Diagnostics (OTCMKTS:VODG) vs. HilleVax (NASDAQ:HLVX) Financial Review - Defense World
HKVX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Stockholders to Contact the Firm! - ACCESS Newswire
HilleVax, Inc. (NASDAQ:HLVX) Shares Purchased by Barclays PLC - Defense World
Jane Street Group LLC Purchases 35,546 Shares of HilleVax, Inc. (NASDAQ:HLVX) - Defense World
HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by Geode Capital Management LLC - Defense World
Barclays PLC Raises Holdings in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Critical Comparison: Zura Bio (NASDAQ:ZURA) versus HilleVax (NASDAQ:HLVX) - Defense World
HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by State Street Corp - Defense World
Cancer Vaccine Breaking News - Vax-Before-Travel
Short Interest in HilleVax, Inc. (NASDAQ:HLVX) Expands By 7.4% - MarketBeat
Charles Schwab Investment Management Inc. Has $133,000 Stake in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Critical Survey: Fate Therapeutics (NASDAQ:FATE) versus HilleVax (NASDAQ:HLVX) - Defense World
Financial Contrast: Vericel (NASDAQ:VCEL) versus HilleVax (NASDAQ:HLVX) - Defense World
HilleVax, Inc. Announces Management Changes - Marketscreener.com
3 US Penny Stocks With Market Caps Under $100M - simplywall.st
HilleVax initiates major workforce reduction, executives depart By Investing.com - Investing.com Australia
HilleVax initiates major workforce reduction, executives depart - Investing.com
HilleVax Shares Rise After Announcing Job Cuts, Executive Departures - MarketWatch
HilleVax, Inc. Announces Workforce Reduction and Leadership Changes - TipRanks
Head to Head Survey: HilleVax (NASDAQ:HLVX) versus NKGen Biotech (NYSE:NKGN) - Defense World
JP Morgan Downgrades HilleVax (HLVX) - MSN
1,064,000 Shares in HilleVax, Inc. (NASDAQ:HLVX) Bought by Braidwell LP - MarketBeat
GSA Capital Partners LLP Acquires New Shares in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
England's Norovirus Outbreak Peaks Early in 2024 - Precision Vaccinations
HilleVax, Inc. (NASDAQ:HLVX) Short Interest Update - MarketBeat
HilleVax (NASDAQ:HLVX) Stock Price Down 1.5% on Disappointing Earnings - Defense World
HilleVax (NASDAQ:HLVX) Stock Price Down 1.5% Following Weak Earnings - MarketBeat
HilleVax Reports Q3 Financial Results Amid Strategic Planning - TipRanks
Hillevax Inc Stock (HLVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):